This study is a prospective, real world study.The objective is to observe the diagnosis and first-line treatment of Chinese patients with cancer of unknown primary, and collect the clinicopathological characteristics, treatment outcomes, survival and other data of the patients.
Study Type
OBSERVATIONAL
Enrollment
200
The patient's treatment is determined by the physician in charge according to the patient's clinical situation and relevant guidelines, without additional intervention.
Fudan University Shanghai Cencer Center
Shanghai, Shanghai Municipality, China
RECRUITINGProgression-free survival (PFS)
Time frame: 8 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.